All treatments
Treatment
Ritlecitinib tosilate clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
B7981040 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
This study is testing a new medicine, Ritlecitinib, for vitiligo, a skin condition where you lose skin colour. It aims to see how well it works and if it's safe for adults and teenagers.
For: NON SEGMENTAL VITILIGOBulgaria · Spain · Germany - AuthorisedTherapeutic confirmatory (Phase III)
B7981028 - A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031
This study is looking long-term at a medicine called ritlecitinib for severe alopecia areata, a condition causing hair loss. It's checking how safe and effective the medicine is in people who were in earlier trials. The goal is to see if it helps with hair regrowth and overall well-being.
For: Alopecia areataItaly · France · Czechia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
B7981032 - A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA
This study is looking at a new medicine called Ritlecitinib to see if it's safe and helps adults and teenagers with alopecia areata. It's a long-term study to understand the side effects and how well it works over time.
For: Alopecia areataGermany · Spain · Poland